The present invention relates to novel strontium salts of fumaric acid monoalkylesters. The salts are suitable for use as active subtances in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders either alone or in combination with another fumaric acid ester.
|Country||International Bureau of the World Intellectual Property Organization (WIPO)|
|Publication status||Published - 2006|